版本:
中国

BRIEF-Active Biotech updates on laquinimod development

Sept 19 Active Biotech Ab :

* Active Biotech update on laquinimod development: U.S, Food and Drug Administration rescinds special protocol assessment for laquinimod Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐